ArticleScientific reports2019

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors.

Kimio Yonesaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.